SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray is trending amid speculation that the Trump administration may be considering easing federal marijuana restrictions, potentially reclassifying it as a Schedule III drug. The community is actively discussing target prices and potential short squeezes, while also speculating on how Tilray and other cannabis stocks will react to the potential policy change.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and the FC SAN business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom's stock is trending due to analyst target price updates and discussions around a recently revealed $10 billion custom AI chip order from Anthropic, now followed by an additional $11 billion order. While some see amazing earnings, others worry about gross margins and question a sky-high valuation; the community is closely watching for a potential dip-buying opportunity.

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Lululemon Athletica Inc

Lululemon is trending following a Q3 earnings beat, a raised full-year guidance, and the announcement of a CEO succession plan and a buyback program. The community is discussing the potential for analyst upgrades and the impact of international business, particularly in China, on the company's future growth. Some traders are noting overnight gains and anticipating a continued run, while others express concerns about overnight crashes and are eyeing the $225-$240 range.

Mawson Infrastructure Group, Inc. engages in the provision of digital asset infrastructure services. The company was founded on February 10, 2012 and is headquartered in Midland, PA.

Mawson Infrastructure Group Inc

MIGI is trending due to a volatile trading session following a reverse stock split and recent ATM offering announcement, with community members debating whether the price action signals a pump and dump scheme or a genuine opportunity. Discussions revolve around the company's market cap requirements for Nasdaq compliance and speculation about potential news catalysts. The stock's low float and high short interest are also contributing to the intense speculation and trading activity.

RH operates as a holding company which operates the business through its subsidiary Restoration Hardware, Inc. It offers furniture, lighting, textiles, bath ware, decor, outdoor and garden, as well as baby and child products. The company operates an integrated business with multiple channels of distribution including galleries, source books and websites. The company was founded by Stephen J. Gordon in 1980 and is headquartered in Corte Madera, CA.

RH - Ordinary Shares - Class A

Restoration Hardware

RH is trending as investors digest recent earnings and forward guidance, with community chatter focused on the CEO's commentary and the potential impact of tariffs. Some believe RH is undervalued and poised for a short squeeze, while others worry about the company's debt and exposure to the housing market.

Yee is a community based memecoin with one mission: to fight Pepe again. Made to honor the iconic meme rivalry we all know and love.  The Yee Legend  [Filed by: Yee’s Archivist & Legal Representative]  There’s something the meme world refuses to talk about: Pepe the Frog stole Yee the Dino’s entire launch plan.  Yee had been preparing for his comeback for months, but Pepe launched two weeks earlier, hijacking Yee’s concept and selling it as his own.  The charges? Meme theft, intellectual forgery, and historical erasure.  Yee’s official contract was filed in April 2023, right after Pepe’s surprise drop. This wasn’t timing—it was theft. The archives are about to open, and history is about to be corrected

Yee Token

$YEE is gaining traction, fueled by community enthusiasm and increasing buying pressure. Discussions highlight its potential within the Ethereum ecosystem, with some drawing comparisons to earlier memecoins and touting a possible 'prophecy' narrative. The community rallies around $YEE's momentum, anticipating further upward movement.

Spirit Realty Capital is a Real Estate Investment Trust (REIT) company located in Scottsdale, Arizona.  Spirit Realty Capital was formed in 2003 to acquire single tenant, “operationally essential” real estate, which refers to generally free-standing, commercial real estate facilities where our tenants conduct retail, service or distribution activities that are essential to the generation of their sales and profits.

Realty Income Corp.

Realty Income ($O) is trending as investors weigh its potential amid fluctuating interest rate expectations and recent analyst rating adjustments. Community discussions revolve around its dividend reliability, global expansion, and comparison to peers like Digital Realty ($DLR) and Agree Realty ($ADC). Some are concerned about its growth prospects and exposure to retail tenants, while others see it as a stable income play for long-term investors, especially with potential rate cuts on the horizon.

Assemble’s AI agent, News3(NS3), was developed with the goal of revolutionizing Web 3.0 journalism. NS3 delivers crypto and global economic trends quickly and clearly, and leverages advanced AI reasoning capabilities to analyze these trends, enabling market participants to make data-driven decisions. In particular, NS3 utilizes OpenAI’s latest reasoning model as its core engine to analyze crypto and economic trends, providing a range of insights including market psychology, past case analysis, future predictions, ripple effects, and investment strategies in 12 languages.

Assemble Protocol

Assemble Protocol ($ASM) is trending amid community excitement and speculation, with some users pointing to AI developments as a catalyst. Community members are actively discussing potential partnerships and bullish technical indicators, with some hoping for a significant price increase. However, there are also concerns about past performance and potential market manipulation.

Ginkgo Bioworks Holdings, Inc. is a biotech company. Its platform enables biotechnology applications across diverse markets, from food, agriculture, industrial chemicals, and pharmaceuticals. It operates through the Cell Engineering and Biosecurity segments. The Cell Engineering segment consists of end-to-end cell engineering solutions and cell engineering tools offerings for biological research and development. The Biosecurity segment focuses on biomonitoring and bioinformatics support services, offered to both government and non-government customers through the company's two core offerings, Canopy and Horizon. The company was founded by Jason Kelly, Reshma Shetty, Bartholomew Canton, Austin Che, and Thomas F. Knight, Jr. in 2008 and is headquartered in Boston, MA.

Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A

DNA is trending as community members discuss the company's growth potential following government support and Biosecure news. Optimistic investors believe it's currently undervalued, drawing parallels to Palantir due to Shyam Sankar's dual role and potential for a short squeeze. Others are expressing concern over recent financial performance, while some traders are actively playing shorter-term technical signals.

UNI is the governance token for Uniswap, an Automated Market Marker DEX on the Ethereum blockchain. The UNI token allows token holders to participate in the governance of the protocol. Key decisions such as usage of the treasury or future upgrades can be decided through a governance vote.

UniSwap

UNI is trending as the community discusses a potential proposal that could significantly reduce its circulating supply through token burns, potentially attracting institutional and retail interest. There is also discussion around how Keeta, a high-performance Layer 1 blockchain, complements Uniswap, offering settlement and interoperability solutions. The community sees potential for a supply shock and anticipates significant price movement if key governance unlocks occur.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

TD Cowen Forecasts Strong Price Appreciation for Royalty Pharma (NASDAQ:RPRX) Stock

TD Cowen lifted their price target on Royalty Pharma from $42.00 to $45.00 and gave the stock a "buy" rating in a report on Thursday...

California Public Employees Retirement System Sells 268,263 Shares of Royalty Pharma PLC $RPRX

California Public Employees Retirement System lessened its stake in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 15.6% in the 2nd quarter, according to the company in its most recent 13F filing...

Royalty Pharma (NASDAQ:RPRX) EVP Sells $913,526.10 in Stock

Royalty Pharma PLC (NASDAQ:RPRX - Get Free Report) EVP Marshall Urist sold 23,334 shares of the firm's stock in a transaction on Friday, December 5th. The shares were sold at an average price of...

Hsbc Holdings PLC Sells 77,498 Shares of Royalty Pharma PLC $RPRX

Hsbc Holdings PLC cut its holdings in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 68.1% in the second quarter, according to the company in its most recent disclosure with the Securities and...

Royalty Pharma PLC $RPRX Holdings Raised by Amundi

Amundi boosted its stake in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 126.1% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The...

Royalty Pharma (NASDAQ:RPRX) EVP Sells $4,374,700.00 in Stock

Royalty Pharma PLC (NASDAQ:RPRX - Get Free Report) EVP George Lloyd sold 110,000 shares of Royalty Pharma stock in a transaction that occurred on Wednesday, December 3rd. The shares were sold at an...

George Lloyd Sells 110,000 Shares of Royalty Pharma (NASDAQ:RPRX) Stock

Royalty Pharma PLC (NASDAQ:RPRX - Get Free Report) EVP George Lloyd sold 110,000 shares of the firm's stock in a transaction on Wednesday, December 3rd. The shares were sold at an average price of...

Denali Enters Into a $275M Funding Deal With Royalty Pharma

DNLI secures a $275M funding deal with Royalty Pharma tied to potential approvals for its Hunter syndrome therapy.

Royalty Pharma PLC $RPRX Shares Acquired by Schroder Investment Management Group

Schroder Investment Management Group boosted its stake in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 130.0% during the 2nd quarter, according to its most recent Form 13F filing with the...

Insider Selling: Royalty Pharma (NASDAQ:RPRX) EVP Sells $931,686.69 in Stock

Royalty Pharma PLC (NASDAQ:RPRX - Get Free Report) EVP Marshall Urist sold 23,333 shares of the stock in a transaction that occurred on Monday, December 1st. The shares were sold at an average price...

Royalty Pharma Plc engages in the provision of drug development services. It operates as a funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals and not-for-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio includes royalties, including AbbVie and J&J’s Imbruvica, Astellas and Pfizer’s Xtandi, Biogen’s Tysabri, Gilead’s HIV franchise, Merck’s Januvia, Novartis’ Promacta, Vertex’s Kalydeco, Orkambi, Symdeko and Trikafta, and five development-stage product candidates. The company was founded by Pablo Gerardo Legorreta and Rory B. Riggs in 1996 and is headquartered in New York, NY.

Royalty Pharma plc - Ordinary Shares - Class A

Bullish: S&P grinds higher

Choppy but up: buy dips

Sideways: fade the move

Bearish: this rally falls off

The Federal Reserve just announced a 0.25 percentage point interest rate cut at its December 10, 2025 meeting.​ Share your outlook on how the latest Federal Reserve interest rate cut will impact stocks and the S&P 500 over the next month.

How do you think today’s Fed rate cut impacts stocks over the next month?

RPRX
Royalty Pharma plc - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest RPRX News

RPRXRoyalty Pharma plc - Ordinary Shares - Class A